Novel ways of approaching the pharmacologic treatment of trigeminal neuralgia

Headache. 2022 May;62(5):540-542. doi: 10.1111/head.14316. Epub 2022 May 6.

Authors

Moises Dominguez¹, Giulia Di Stefano²

Affiliations

¹ Department of Neurology, Weill Cornell Medicine & New York-Presbyterian, New York, New York, USA.
² Department of Human Neuroscience, Sapienza University, Rome, Italy.

PMID: 35524406
DOI: 10.1111/head.14316

No abstract available

Keywords: calcitonin gene-related peptide; carbon dioxide; facial pain disorder; sodium-channel blockers; trigeminal neuralgia.

Publication types

Editorial
Comment

MeSH terms

Humans
Pain Measurement
Trigeminal Neuralgia* / drug therapy